National Institute for Infectious Diseases
National Institute for Infectious Diseases (INMI) – “Lazzaro Spallanzani”
The National Institute for Infectious Diseases (INMI) “Lazzaro Spallanzani” is a public research institution dedicated to infectious diseases operating since 1936. INMI is recognized as a leader in infectious diseases research, and ranked as a top level institution for publication impact in the fields of infectious diseases, epidemiology and microbiology. INMI is the Italian National Referral Centre for the management and diagnosis of highly transmissible infectious diseases. Since 2003 INMI is member of the Global Outbreak Alert and Response Network (WHO), and in 2009 it was appointed as a WHO collaborative center for clinical care, diagnosis, response and training on “Highly Infectious Diseases.”
It is also the Italian reference center for the diagnosis of deliberately released high treat biological agents (Class A agents). The paradigm of INMI activity is to hold in a strict connection, i.e. in physical proximity, both patient care and laboratory facilities, to have concentrated in one single institution all professional expertise and structures required to complete the cycle of management of patients with highly infectious diseases. INMI research agenda is mainly focused on emerging and re-emerging infections, blood-borne pathogens (including HIV, HBV and HCV infections), Tuberculosis and tropical diseases. On these topics INMI cover basic, pathogenetic, diagnostic, epidemiologic, care/treatment and prevention research. A high-level technology park, composed of state-of-the-art technological platforms, offers cutting-edge equipment and know-how.